Beverley M. Shields

Active 2004–2025

Also published as
Beverley M Shields
97
Papers
22,933
Citations
67
h-index
91
i10-index

Citations

Citations per year for Beverley M. Shields1974: 3 citations1983: 1 citations1993: 1 citations1999: 1 citations2002: 1 citations2005: 7 citations2006: 18 citations2007: 141 citations2008: 444 citations2009: 418 citations2010: 347 citations2011: 305 citations2012: 321 citations2013: 256 citations2014: 259 citations2015: 225 citations2016: 212 citations2017: 199 citations2018: 243 citations2019: 597 citations2020: 744 citations2021: 613 citations2022: 559 citations2023: 388 citations2024: 545 citations2025: 328 citations2026: 15 citations1975–1982: no citations, so these years are not shown1984–1992: no citations, so these years are not shown1994–1998: no citations, so these years are not shown2000–2001: no citations, so these years are not shown2003–2004: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,230 citing papers, 19.8% of this breakdownUnited Kingdom: 1,432 citing papers, 12.7% of this breakdownChina: 754 citing papers, 6.7% of this breakdownGermany: 513 citing papers, 4.5% of this breakdownSweden: 436 citing papers, 3.9% of this breakdownAustralia: 423 citing papers, 3.8% of this breakdownNetherlands: 412 citing papers, 3.7% of this breakdownCanada: 400 citing papers, 3.5% of this breakdownItaly: 379 citing papers, 3.4% of this breakdownFinland: 319 citing papers, 2.8% of this breakdownDenmark: 306 citing papers, 2.7% of this breakdownFrance: 302 citing papers, 2.7% of this breakdown
0%19.8%Other 29.8%

Fields

  • Biochemistry, Genetics and Molecular Biology47.3%
  • Medicine43.9%
  • Neuroscience2.5%
  • Nursing1%
  • Computer Science0.8%
  • Psychology0.7%
  • Other3.8%

Topics

  • Genetic Associations and Epidemiology9.8%
  • Pancreatic function and diabetes7.1%
  • Diabetes and associated disorders5.2%
  • Diabetes Management and Research3.3%
  • RNA modifications and cancer3%
  • Diabetes Treatment and Management2.7%
  • Other68.9%

Coauthors

All papers

Open in search
  1. A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fredrik Karpe, Katharine R. Owen, Lon R. Cardon, Mark Walker, G. A. Hitman, Colin N. A. Palmer, Alex S. F. Doney, Andrew D. Morris, George Davey Smith, Andrew T. Hattersley, Mark I. McCarthy - Science 2007 cited by 4,505

  2. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data

    Authors: , , , , - The Lancet Diabetes & Endocrinology 2019 cited by 474

  3. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank

    Authors: , , , , , - The Lancet Diabetes & Endocrinology 2017 cited by 404

  4. A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults

    Authors: , , , , , , , - Diabetes Care 2015 cited by 369

  5. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roza Blagieva, Eric Boerwinkle, Lori L. Bonnycastle, Kristina Bengtsson Boström, Bert Bravenboer, Suzannah Bumpstead, Noisël P Burtt, G. Charpentier, Peter S. Chines, Marilyn C. Cornelis, David Couper, Gabe Crawford, Alex S. F. Doney, Katherine S. Elliott, Amanda L. Elliott, Michael R. Erdos, Caroline S. Fox, Christopher S. Franklin, Martha Ganser, Christian Gieger, Niels Grarup, Todd J. Green, Simon J. Griffin, Christopher J. Groves, Candace Guiducci, Samy Hadjadj, Neelam Hassanali, Christian Herder, Bo Isomaa, Anne Jackson, Paul R V Johnson, Torben Jørgensen, Wen H. Kao, Norman Klopp, Augustine Kong, Peter Kraft, Johanna Kuusisto, Torsten Lauritzen, Man Li, Aloysius G. Lieverse, Cecilia M. Lindgren, Valeriya Lyssenko, Michel Marre, Thomas Meitinger, Kristian Midthjell, Mario A. Morken, Narisu Narisu, Peter M. Nilsson, Katharine R. Owen, Felicity Payne, John R. B. Perry, Ann-Kristin Petersen, Carl G. P. Platou, Christine Proença, Inga Prokopenko, Wolfgang Rathmann, Nigel W. Rayner, Neil R. Robertson, Ghislain Rocheleau, Michael Roden, Michael Sampson, Richa Saxena, Beverley M. Shields, Peter Shrader, Gunnar Sigurðsson, Thomas Sparsø, Klaus Straßburger, Heather M. Stringham, Qi Sun, Amy J. Swift and 59 more - Nature Genetics 2010 cited by 1,797

  6. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leda Chatzi, Jordi Sunyer, Ana Jiménez-Zabala, Isolina Riaño, Mario Murcia, Xuemian Lu, Shafqat Mukhtar, Christian Delles, Ulla Feldt‐Rasmussen, Scott M. Nelson, Erik K. Alexander, Layal Chaker, Tuija Männistö, John P. Walsh, Elizabeth N. Pearce, Eric A.P. Steegers, Robin P. Peeters - JAMA 2019 cited by 387

  7. Prevalence of Vascular Complications Among Patients With Glucokinase Mutations and Prolonged, Mild Hyperglycemia

    Authors: , , , , , - JAMA 2014 cited by 380

  8. Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis

    Authors: , , , , , , , , - Diabetologia 2020 cited by 165

  9. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher J. Groves, Candace Guiducci, Torben Hansen, Christian Herder, G. A. Hitman, Thomas E. Hughes, Bo Isomaa, Anne Jackson, Torben Jørgensen, Augustine Kong, Kari Kubalanza, Finny G. Kuruvilla, Johanna Kuusisto, Claudia Langenberg, Hana Lango Allen, Torsten Lauritzen, Yun Li, Cecilia M. Lindgren, Valeriya Lyssenko, Amanda F. Marvelle, Christa Meisinger, Kristian Midthjell, Karen L. Mohlke, Mario A. Morken, Andrew D. Morris, Narisu Narisu, Peter M. Nilsson, Katharine R. Owen, Colin NA Palmer, Felicity Payne, John R. B. Perry, Elin Pettersen, Carl G. P. Platou, Inga Prokopenko, Lu Qi, Qin Li, Nigel W. Rayner, Matthew G. Rees, Jeffrey J. Roix, Anelli Sandbæk, Beverley M. Shields, Marketa Sjögren, Valgerður Steinthórsdóttir, Heather M. Stringham, Amy J. Swift, Gudmar Thorleifsson, Unnur Þorsteinsdóttir, Nicholas J. Timpson, Tiinamaija Tuomi, Jaakko Tuomilehto, Mark Walker, Richard M. Watanabe, Michael N. Weedon, Cristen J. Willer, Thomas Illig, Kristian Hveem, Frank B. Hu, Markku Laakso, Kāri Stefánsson, Oluf Pedersen, Nicholas J. Wareham, Inês Barroso, Andrew T. Hattersley, Francis S. Collins, Leif Groop, Mark I. McCarthy, Michael Boehnke, David Altshuler - Nature Genetics 2008 cited by 1,877

  10. Maturity-onset diabetes of the young (MODY): how many cases are we missing?

    Authors: , , , , , - Diabetologia 2010 cited by 719

  11. Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

    Authors: , , , , , , , , - Diabetologia 2019 cited by 186

  12. Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation

    Authors: , , , , , , , , - BMJ Open Diabetes Research & Care 2020 cited by 100

  13. Genetic effects on the timing of parturition and links to fetal birth weight

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Octavious Talbot, Catherine Allard, Scott M. Williams, Ramkumar Menon, Beverley M. Shields, Garðar Sveinbjörnsson, Huan Xu, Mads Melbye, William L. Lowe, Luigi Bouchard, Emily Oken, Ole Birger Pedersen, Daníel F. Guðbjartsson, Christian Erikstrup, Erik Sørensen, Mark I. McCarthy, Rolv T. Lie, Kari Teramo, Mikko Hallman, Thorhildur Juliusdottir, Hakon Hakonarson, Henrik Ullum, Andrew T. Hattersley, Line Sletner, Mario Merialdi, Sheryl L. Rifas‐Shiman, Þóra Steingrímsdóttir, Denise Scholtens, Christine Power, Jane West, Mette Nyegaard, John A Capra, Anne Heidi Skogholt, Per Magnus, Ole A. Andreassen, Unnur Thorsteinsdottir, Struan F.A. Grant, Elisabeth Qvigstad, Craig E. Pennell, Marie‐France Hivert, M. Geoffrey Hayes, Marjo‐Riitta Järvelin, Mark I. McCarthy, Debbie A. Lawlor, Henriette Svarre Nielsen, Reedik Mägi, Antonis Rokas, Kristian Hveem, Kāri Stefánsson, Bjarke Feenstra, Pål R. Njølstad, Louis J Muglia, Rachel M. Freathy, Stefan Johansson, Ge Zhang, Bo Jacobsson - Nature Genetics 2023 cited by 95

  14. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation

    Authors: , , , , , , - Diabetes Care 2015 cited by 290

  15. Logistic regression has similar performance to optimised machine learning algorithms in a clinical setting: application to the discrimination between type 1 and type 2 diabetes in young adults

    Authors: , , , , , , - Diagnostic and Prognostic Research 2020 cited by 136

  16. Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes

    Authors: , , , , - Diabetes Care 2021 cited by 113

  17. Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes

    Authors: , , , , , , - Diabetes Care 2015 cited by 176

  18. Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2007 cited by 2,211

  19. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes

    Authors: , , , , , - Diabetologia 2012 cited by 332

  20. Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study

    Authors: , , , , , , , , , , , - Nature Medicine 2022 cited by 70

  21. Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study

    Authors: , , , , , , , , , , , , - The Lancet Digital Health 2022 cited by 54

  22. Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data

    Authors: , , , , , , , , , , , , , , , , , , , , - Diabetes Care 2018 cited by 135

  23. The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

    Authors: , , , , , , , - Diabetologia 2013 cited by 297

  24. Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years

    Authors: , , , , , , , , , , - BMJ Open 2019 cited by 73